<?xml version="1.0" encoding="UTF-8"?><urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"><url><loc>https://www.thefocalpoints.com/p/the-war-is-not-meant-to-be-won</loc><news:news><news:publication><news:name>FOCAL POINTS (Courageous Discourse™)</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-07-23T18:53:43+00:00</news:publication_date><news:title>The War is Not Meant to Be Won</news:title></news:news></url><url><loc>https://www.thefocalpoints.com/p/sweat-with-purpose-exercise-in-the</loc><news:news><news:publication><news:name>FOCAL POINTS (Courageous Discourse™)</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-07-23T09:27:53+00:00</news:publication_date><news:title>Sweat With Purpose: Exercise in the Heat to Unlock Your Body's Deepest Detox</news:title></news:news></url><url><loc>https://www.thefocalpoints.com/p/new-study-aggressive-cancer-patients</loc><news:news><news:publication><news:name>FOCAL POINTS (Courageous Discourse™)</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-07-22T14:17:54+00:00</news:publication_date><news:title>NEW STUDY: Aggressive Cancer Patients Had 82% Less Bifidobacterium in Their Gut Compared With Healthy Adults</news:title></news:news></url><url><loc>https://www.thefocalpoints.com/p/mercks-lipfendra-enlicitide-the-first</loc><news:news><news:publication><news:name>FOCAL POINTS (Courageous Discourse™)</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-07-22T09:41:10+00:00</news:publication_date><news:title>Merck’s Lipfendra (Enlicitide): The First Oral PCSK9 Inhibitor Arrives</news:title></news:news></url></urlset>